Product image of Librium (Chlordiazepoxide Hydrochloride) supplied by GNH India

Librium

Active Ingredient:
Chlordiazepoxide Hydrochloride
Origin:
EU

Librium (Chlordiazepoxide Hydrochloride)

Chlordiazepoxide, the active ingredient in Librium, is a benzodiazepine presented as an oral tablet for oral use. It is employed to manage anxiety disorders, alleviate symptoms of alcohol withdrawal, and provide short‑term sedation in adult patients. It is commonly prescribed for short‑term relief of anxiety symptoms, as part of medically supervised detoxification from alcohol, and for procedural sedation when rapid calming is required.

GNH India supplies Librium as a licensed, GDP‑compliant international pharmaceutical supplier, providing rigorously quality‑tested product to hospitals, pharmacies and clinics worldwide, backed by comprehensive regulatory compliance and reliable logistics.

Manufacturer / TM Owner

Mylan Products Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Librium (chlordiazepoxide) acts on the central nervous system GABAergic pathway to treat several anxiety‑related conditions and related withdrawal states.

  • Anxiety disorders: reduces excessive nervous tension and anxiety symptoms.
  • Alcohol withdrawal syndrome: mitigates agitation, tremor and risk of seizures during detoxification.
  • Sedation: provides short‑term calming for procedures requiring patient relaxation.

How It Works

  • Chlordiazepoxide binds to an allosteric site on the GABA‑A receptor complex, enhancing the affinity of the receptor for the inhibitory neurotransmitter gamma‑aminobutyric acid (GABA). This positive allosteric modulation increases chloride ion influx, hyperpolarizing neuronal membranes and producing a generalized depressant effect on central nervous system activity, which underlies its anxiolytic, sedative and anticonvulsant properties. The resultant increase in inhibitory signaling reduces neuronal excitability, contributing to the therapeutic calming effect.

Side Effects

Chlordiazepoxide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Drowsiness: feeling of sleepiness or reduced alertness.
  • Dizziness: light‑headed sensation, especially when standing quickly.
  • Fatigue: general lack of energy or increased tiredness.
  • Impaired coordination: reduced motor control leading to clumsiness.

Serious or Rare Side Effects

  • Respiratory depression: slowed or shallow breathing, potentially life‑threatening.
  • Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
  • Dependence and withdrawal: risk of physical dependence with prolonged use, leading to withdrawal symptoms upon abrupt cessation.

Precautions & Warnings

When prescribing chlordiazepoxide, clinicians should consider several safety measures.

  • Pregnancy: category D; use only if benefits outweigh risks.
  • Elderly patients: increased sensitivity; start with lower dose and monitor closely.
  • History of substance abuse: risk of dependence; limit duration of therapy.
  • Concurrent CNS depressants: may enhance sedation and respiratory depression; avoid combination.
  • Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.

Avoid Interactions

Chlordiazepoxide interacts with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid)

  • Opioids: combined CNS depression can cause profound respiratory depression.
  • Barbiturates: additive sedative effect may lead to severe CNS depression.
  • Alcohol: synergistic depressant effect increases risk of overdose.

Moderate Interactions (Monitor Closely)

  • Antidepressants (SSRIs, SNRIs): may increase sedation.
  • Antihistamines: can enhance drowsiness.
  • CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may raise chlordiazepoxide plasma levels.

Frequently Asked Questions

Librium (chlordiazepoxide) is prescribed for anxiety disorders, to alleviate symptoms during alcohol withdrawal syndrome, and for short‑term sedation in procedures where rapid calming of the patient is needed.

Chlordiazepoxide enhances the activity of the neurotransmitter GABA at the GABA‑A receptor, increasing chloride influx into neurons. This amplifies inhibitory signaling, leading to reduced neuronal excitability and producing anxiolytic, sedative, and anticonvulsant effects.

The appropriate dose of Librium is determined by the prescribing clinician based on the individual’s medical condition, age, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Librium is classified as pregnancy category D, indicating evidence of risk to the fetus. It should be used only if the potential benefits justify the risks. Breastfeeding is not recommended because the drug can pass into milk and affect the infant.

To request Librium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Librium (chlordiazepoxide) has a relatively long half‑life compared with agents such as lorazepam, making it useful for managing alcohol withdrawal where a smoother taper is desired. Its onset is slower than some short‑acting benzodiazepines, which may be preferred for acute anxiety episodes.

Librium should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Librium is taken orally as a tablet. The prescriber will indicate whether it should be taken with food or on an empty stomach, and the exact timing relative to other medications.

The most serious risks include respiratory depression, especially when combined with other CNS depressants, severe allergic reactions, and the potential for physical dependence and withdrawal symptoms after prolonged use.

Librium is contraindicated in patients with known hypersensitivity to chlordiazepoxide or other benzodiazepines, those with acute narrow‑angle glaucoma, and individuals with severe respiratory insufficiency. Caution is also advised for patients with a history of substance misuse.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Chlordiazepoxide Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT